Abstract
B7-H4 has been shown to inhibit T cell proliferation, cytokine production and cell cycle in vitro. B7-H4 deficient mice develop exacerbated disease in the mouse models of Rheumatoid Arthritis (RA), Type 1 Diabetes (T1D) and Experimental Autoimmune Encephalomyelitis (EAE). On the other hand, B7-H4-Ig fusion protein has been documented to assuage the symptoms in mouse models of RA, T1D, and multiple sclerosis in vivo. In the present study, B7-H4-Ig bound to the majority of human peripheral blood monocytes and NK cells, but not to either normal or activated T cells. B7-H4-Ig fusion protein was assayed for its effects in allogeneic mixed lymphocyte culture (MLC) systems. Soluble B7- H4-Ig had no significant effect in the MLC, but with a tendency to promote allogeneic response. Immobilized, but not soluble B7-H4-Ig inhibited plastic bound anti-CD3 mediated activation of T cells. This inhibition however was largely due to B7-H4-Ig mediated displacement of anti-CD3 antibody from the plastic plate. Finally, B7-H4-Ig had no effect on the cytotoxicity mediated by NK and LAK cells in PBMC. Our findings thus caution against the interpretation of suppressive effect observed solely in plate-bound anti-CD3 mediated T cell co-stimulation in vitro.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Open Journal of Immunology |
| Vol/bind | 3 |
| Udgave nummer | 1 |
| Sider (fra-til) | 24-32 |
| Antal sider | 9 |
| ISSN | 2162-450X |
| DOI | |
| Status | Udgivet - 2013 |
Emneord
- Det Sundhedsvidenskabelige Fakultet
- CD28 Family
- B7-H4
- Fusion Protein
- MLC
FN’s Verdensmål
Dette resultat bidrager til følgende verdensmål
